Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-817-9 | CAS number: 78014-16-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
oral: LD50 is approx. 500 mg/kg bw
dermal/inhalation: the study does not need to be conducted since the substance is classified as corrosive to the skin
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 8-12 weeks (at study initiation)
- Weight at study initiation: 145-160 g
- Fasting period before study: overnight and approximately 3-4 hours after dosing
- Housing: 3 animals/cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25°C
- Humidity (%): 30-70%
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- For the purpose of the study the test item was freshly prepared, as required, as a solution at the appropriate concentration in distilled water.
- Doses:
- 2000 and 300 mg/kg b.w.
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: at 0.5, 1, 2 and 4 h after dosing and once daily thereafter
- Frequency of weighing: day 0 (prior to dosing), day 7 and day 14
- Necropsy of survivors performed: yes
- Other examinations performed: gross examination of organs at necropsy - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- ca. 500 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Animals treated at a dose level of 2000 mg/kg bw were found dead six hours or one day after dosing. There were no deaths at a dose level of 300 mg/kg bw.
- Clinical signs:
- other: Signs of systemic toxicity noted at both dose levels were hunched posture, ataxia and ptosis. Noisy respiration and/or lethargy were also noted in animals treated at a dose level of 2000 mg/kg. Surviving animals appeared normal one hour to one day after d
- Gross pathology:
- Abnormalities noted at necropsy of animals that died during the study were haemorrhagic lungs, dark liver, gaseous stomach, haemorrhage,
epithelial sloughing and raised limiting ridge of the gastric mucosa, epithelial sloughing and reddened non-glandular region of the stomach,
gaseous small intestine, solid food matter and/or green, clear red or reddish/brown coloured liquid present in the stomach and dark green
substance present in the large intestine. No abnormalities were noted at necropsy of animals treated at a dose level of 300 mg/kg. - Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- The LD50 of the test item in the female Wistar strain rat was approximately 500 mg/kg bw.
- Executive summary:
A group of three fasted female Wistar rats was treated with the test item at a dose level of 2000 mg/kg bw. Based on the results from this dose level further groups of fasted females were treated at a dose level of 300 mg/kg bw.
Animals treated at a dose level of 2000 mg/kg bw were found dead six hours or one day after dosing. There were no deaths at a dose level of 300 mg/kg bw.
Signs of systemic toxicity noted were hunched posture, ataxia and ptosis. Noisy respiration and/or lethargy were also noted in animals treated at a dose level of 2000 mg/kg bw. Surviving animals appeared normal one hour to one day after dosing. The surviving animals showed expected gains in bodyweight over the study period.
Abnormalities noted at necropsy of animals that died during the study were haemorrhagic lungs, dark liver, gaseous stomach, haemorrhage, epithelial sloughing and reddened non-glandular region of the stomach, gaseous small intestine, solid food matter and/or liquid present in the stomach and dark green substance present in the large intestine. No abnormalities were noted at necropsy of animals treated at a dose level of 300 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 500 mg/kg bw
- Quality of whole database:
- reliable without restriction
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The acute oral toxicity of the substance was tested in the rat according to the acute toxic class method (OECD 423). A group of three fasted females was treated with the test item solved in distilled water at a dose level of 2000 mg/kg bw. Animals treated at a dose level of 2000 mg/kg were found dead six hours or one day after dosing. Based on the results from this dose level further groups of fasted females were treated at a dose level of 300 mg/kg bw. No deaths occurred at a dose level of 300 mg/kg bw. Signs of systemic toxicity noted were hunched posture, ataxia and ptosis. Noisy respiration and/or lethargy were also noted in animals treated at a dose level of 2000 mg/kg bw. Surviving animals appeared normal one hour to one day after dosing. Abnormalities noted at necropsy of animals dosed with 2000 mg/kg bw were haemorrhagic lungs, dark liver, gaseous stomach, haemorrhage, epithelial sloughing and raised limiting ridge of the gastric mucosa, epithelial sloughing and reddened non-glandular region of the stomach, gaseous small intestine, solid food matter and/or liquid present in the stomach and dark green substance present in the large intestine. No abnormalities were noted at necropsy of animals treated at a dose level of 300 mg/kg bw. The acute oral median lethal dose (LD50) of the test item in the female
Wistar strain rat was approx. 500 mg/kg bw.
Due to the corrosive properties of the substance no acute dermal or inhalation toxicity studies were performed.
Justification for selection of acute toxicity – oral endpoint
One valid GLP compliant acute oral toxicity study is available.
Justification for classification or non-classification
The acute oral toxicity of the substance was tested in the female Wistar rat according to the acute toxic class method (OECD 423). The LD50 cut-off according to OECD TG 423 was 500 mg/kg bw. Thus, the substance is classified in Category 4 according to Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.